Patent details

Basic Information

Publication number:

EP3595725

PCT Application Number:

US2018022961

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP187154414

PCT Publication Number:

WO2018170447

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPIES FOR THE TREATMENT OF BREAST CANCER

French Title of Invention:

TRAITEMENT EN COMBINAISON POUR LE TRAITEMENT DU CANCER DU SEIN

German Title of Invention:

KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON BRUSTKREBS

SPC Number:

Dates

Filing date:

16/03/2018

Grant date:

03/05/2023

EP Publication Date:

22/01/2020

PCT Publication Date:

20/09/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/05/2023

EP B1 Publication Date:

03/05/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/03/2024

Expiration date:

16/03/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/04/2023

 

 

Name:

Eisai R&D Management Co., Ltd.

Address:

6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, Japan (JP)

Inventor

1

Name:

RIOUX, Nathalie

Address:

United States (US)

2

Name:

KARR, Craig D.

Address:

United States (US)

3

Name:

SMITH, Peter Gerard

Address:

United States (US)

4

Name:

KORPAL, Manav

Address:

United States (US)

Priority

Priority Number:

201762472345 P

Priority Date:

16/03/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 45/06; A61K 31/445; A61K 31/519; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202318

Publication date:

03/05/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages